Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era.
Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era.
复制标题
DOI:
10.1038/s41467-022-32404-y
复制
发表时间:
2022-08-19
影响因子:
16.6
通讯作者:
Edmunds, W. John
中科院分区:
文献类型:
--
作者:
Barnard, Rosanna C.;Davies, Nicholas G.;Jit, Mark;Edmunds, W. John
England has experienced a heavy burden of COVID-19, with multiple waves of SARS-CoV-2 transmission since early 2020 and high infection levels following the emergence and spread of Omicron variants since late 2021. In response to rising Omicron cases, booster vaccinations were accelerated and offered to all adults in England. Using a model fitted to more than 2 years of epidemiological data, we project potential dynamics of SARS-CoV-2 infections, hospital admissions and deaths in England to December 2022. We consider key uncertainties including future behavioural change and waning immunity and assess the effectiveness of booster vaccinations in mitigating SARS-CoV-2 disease burden between October 2021 and December 2022. If no new variants emerge, SARS-CoV-2 transmission is expected to decline, with low levels remaining in the coming months. The extent to which projected SARS-CoV-2 transmission resurges later in 2022 depends largely on assumptions around waning immunity and to some extent, behaviour, and seasonality. This mathematical modelling study projects the dynamics of SARS-CoV-2 in England until the end of 2022 assuming that the Omicron BA.2 sublineage remains dominant. They show that booster vaccination was highly effective in mitigating severe outcomes and that future dynamics will depend greatly on assumptions about waning immunity.
登录
查看更多内容
DOI:
10.1126/science.abg3055
发表时间:
2021-04-09
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Davies NG;Abbott S;Barnard RC;Jarvis CI;Kucharski AJ;Munday JD;Pearson CAB;Russell TW;Tully DC;Washburne AD;Wenseleers T;Gimma A;Waites W;Wong KLM;van Zandvoort K;Silverman JD;CMMID COVID-19 Working Group;COVID-19 Genomics UK (COG-UK) Consortium;Diaz-Ordaz K;Keogh R;Eggo RM;Funk S;Jit M;Atkins KE;Edmunds WJ
通讯作者:
Edmunds WJ
DOI:
10.1056/nejmoa2119451
发表时间:
2022-04-21
期刊:
The New England journal of medicine
影响因子:
--
作者:
Andrews N;Stowe J;Kirsebom F;Toffa S;Rickeard T;Gallagher E;Gower C;Kall M;Groves N;O'Connell AM;Simons D;Blomquist PB;Zaidi A;Nash S;Iwani Binti Abdul Aziz N;Thelwall S;Dabrera G;Myers R;Amirthalingam G;Gharbia S;Barrett JC;Elson R;Ladhani SN;Ferguson N;Zambon M;Campbell CNJ;Brown K;Hopkins S;Chand M;Ramsay M;Lopez Bernal J
通讯作者:
Lopez Bernal J
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
3.8
作者:
Endo, Akira;van Leeuwen, Edwin;Baguelin, Marc
通讯作者:
Baguelin, Marc
DOI:
10.1016/s2666-5247(21)00267-6
发表时间:
2022-01
期刊:
The Lancet. Microbe
影响因子:
--
作者:
Cromer D;Steain M;Reynaldi A;Schlub TE;Wheatley AK;Juno JA;Kent SJ;Triccas JA;Khoury DS;Davenport MP
通讯作者:
Davenport MP